553 related articles for article (PubMed ID: 34526087)
41. Use of nebulized liposomal amphotericin B and posaconazole as antifungal prophylaxis in patients with severe SARS-CoV2 infection in intensive care unit.
Fumarola B; Signorini L; Lorenzotti S; Lanza P; Saccani B; Van Hauwermeiren E; Mulè A; Piva S; Rota M; Zuccalà F; Rasulo FA; Filippini M; Bertazzoli A; Del Fabro G; Matteelli A
Infection; 2024 Mar; ():. PubMed ID: 38530518
[TBL] [Abstract][Full Text] [Related]
42. Incidence and mortality of COVID-19-associated pulmonary aspergillosis: A systematic review and meta-analysis.
Mitaka H; Kuno T; Takagi H; Patrawalla P
Mycoses; 2021 Sep; 64(9):993-1001. PubMed ID: 33896063
[TBL] [Abstract][Full Text] [Related]
43. Risk factors for COVID-19-associated pulmonary aspergillosis: a systematic review and meta-analysis.
Gioia F; Walti LN; Orchanian-Cheff A; Husain S
Lancet Respir Med; 2024 Mar; 12(3):207-216. PubMed ID: 38185135
[TBL] [Abstract][Full Text] [Related]
44. Comparison of risk factors and outcome of patients with and without COVID-19-associated pulmonary aspergillosis from Pakistan: A case-control study.
Nasir N; Farooqi J; Zubair SM; Ayub M; Khan S; Wiqar MH; Mahmood SF; Jabeen K
Mycoses; 2023 Jan; 66(1):69-74. PubMed ID: 36111367
[TBL] [Abstract][Full Text] [Related]
45. Regional Impact of COVID-19-Associated Pulmonary Aspergillosis (CAPA) during the First Wave.
Bentvelsen RG; Arkel ALEV; Rijpstra TA; Kant MKM; Brugge SVS; Loth DW; Van Wijngaarden P; Mée AWFD; Yick DCY; Diederen BMW; Wever PC; Leenders ACAP; Van Dommelen L; Groot KH; Van den Bijllaardt W; Verweij PE
J Fungi (Basel); 2022 Jan; 8(2):. PubMed ID: 35205851
[TBL] [Abstract][Full Text] [Related]
46. COVID-19-associated pulmonary aspergillosis (CAPA) in patients admitted with severe COVID-19 pneumonia: An observational study from Pakistan.
Nasir N; Farooqi J; Mahmood SF; Jabeen K
Mycoses; 2020 Aug; 63(8):766-770. PubMed ID: 32585069
[TBL] [Abstract][Full Text] [Related]
47. Pulmonary aspergillosis in critically ill patients with Coronavirus Disease 2019 (COVID-19).
Dupont D; Menotti J; Turc J; Miossec C; Wallet F; Richard JC; Argaud L; Paulus S; Wallon M; Ader F; Persat F
Med Mycol; 2021 Jan; 59(1):110-114. PubMed ID: 32914189
[TBL] [Abstract][Full Text] [Related]
48. COVID-19-associated pulmonary aspergillosis: an underdiagnosed or overtreated infection?
Rouzé A; Martin-Loeches I; Nseir S
Curr Opin Crit Care; 2022 Oct; 28(5):470-479. PubMed ID: 35950729
[TBL] [Abstract][Full Text] [Related]
49. Mortality in critically ill patients with coronavirus disease 2019-associated pulmonary aspergillosis: A systematic review and meta-analysis.
Singh S; Verma N; Kanaujia R; Chakrabarti A; Rudramurthy SM
Mycoses; 2021 Sep; 64(9):1015-1027. PubMed ID: 34057252
[TBL] [Abstract][Full Text] [Related]
50. Pulmonary Aspergillosis in Critically Ill COVID-19 Patients Admitted to the Intensive Care Unit: A Retrospective Cohort Study.
Bergmann F; Jorda A; Blaschke A; Gabler C; Bohdan S; Nussbaumer-Pröll A; Radtke C; Zeitlinger M
J Fungi (Basel); 2023 Mar; 9(3):. PubMed ID: 36983483
[TBL] [Abstract][Full Text] [Related]
51. Metagenomic Next-Generation Sequencing of Plasma for Diagnosis of COVID-19-Associated Pulmonary Aspergillosis.
Hoenigl M; Egger M; Price J; Krause R; Prattes J; White PL
J Clin Microbiol; 2023 Mar; 61(3):e0185922. PubMed ID: 36809121
[TBL] [Abstract][Full Text] [Related]
52. A Pathology-based Case Series of Influenza- and COVID-19-associated Pulmonary Aspergillosis: The Proof Is in the Tissue.
Vanderbeke L; Jacobs C; Feys S; Reséndiz-Sharpe A; Debaveye Y; Hermans G; Humblet-Baron S; Lagrou K; Meersseman P; Peetermans M; Seldeslachts L; Vanstapel A; Vande Velde G; Van Wijngaerden E; Wilmer A; Verbeken E; De Hertogh G; Wauters J
Am J Respir Crit Care Med; 2023 Aug; 208(3):301-311. PubMed ID: 37311243
[No Abstract] [Full Text] [Related]
53. Epidemiology and Incidence of COVID-19-Associated Pulmonary Aspergillosis (CAPA) in a Greek Tertiary Care Academic Reference Hospital.
Paramythiotou E; Dimopoulos G; Koliakos N; Siopi M; Vourli S; Pournaras S; Meletiadis J
Infect Dis Ther; 2021 Sep; 10(3):1779-1792. PubMed ID: 34260038
[TBL] [Abstract][Full Text] [Related]
54. Clinical characteristics, bacterial coinfections and outcomes in COVID-19-associated pulmonary aspergillosis in a third-level Mexican hospital during the COVID-19 pre-vaccination era.
Hernández-Silva G; Corzo-León DE; Becerril-Vargas E; Peralta-Prado AB; Odalis RG; Morales-Villarreal F; Ríos-Ayala MA; Alonso TG; Agustín FD; Ramón AF; Hugo AV
Mycoses; 2024 Jan; 67(1):e13693. PubMed ID: 38214372
[TBL] [Abstract][Full Text] [Related]
55. Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis.
Verweij PE; Brüggemann RJM; Azoulay E; Bassetti M; Blot S; Buil JB; Calandra T; Chiller T; Clancy CJ; Cornely OA; Depuydt P; Koehler P; Lagrou K; de Lange D; Lass-Flörl C; Lewis RE; Lortholary O; Liu PL; Maertens J; Nguyen MH; Patterson TF; Rijnders BJA; Rodriguez A; Rogers TR; Schouten JA; Wauters J; van de Veerdonk FL; Martin-Loeches I
Intensive Care Med; 2021 Aug; 47(8):819-834. PubMed ID: 34160631
[TBL] [Abstract][Full Text] [Related]
56. Usefulness of Sōna Aspergillus Galactomannan LFA with digital readout as diagnostic and as screening tool of COVID-19 associated pulmonary aspergillosis in critically ill patients. Data from a multicenter prospective study performed in Argentina.
Giusiano G; Fernández NB; Vitale RG; Alvarez C; Ochiuzzi ME; Santiso G; Cabeza MS; Tracogna F; Farías L; Afeltra J; Noblega LM; Giuliano CV; Garcia-Effron G
Med Mycol; 2022 May; 60(5):. PubMed ID: 35394043
[TBL] [Abstract][Full Text] [Related]
57. Incidence and outcomes of patients with COVID-19 associated pulmonary aspergillosis (CAPA) in intensive care units: a systematic review and meta-analysis of 31 cohort studies.
Chen W; Yin C; Zhong M; Hu B; Gao X; Zhang K; Liu Y; Zhuang G
Ann Palliat Med; 2022 Jul; 11(7):2202-2209. PubMed ID: 35272474
[TBL] [Abstract][Full Text] [Related]
58. Invasive pulmonary aspergillosis in the COVID-19 era: An expected new entity.
Machado M; Valerio M; Álvarez-Uría A; Olmedo M; Veintimilla C; Padilla B; De la Villa S; Guinea J; Escribano P; Ruiz-Serrano MJ; Reigadas E; Alonso R; Guerrero JE; Hortal J; Bouza E; Muñoz P;
Mycoses; 2021 Feb; 64(2):132-143. PubMed ID: 33210776
[TBL] [Abstract][Full Text] [Related]
59. Significance of Aspergillus spp. isolation in defining cases of COVID-19 Associated Pulmonary Aspergillosis - CAPA.
Cocio TA; Siqueira LPM; Riciluca KCT; Gimenes VMF; de Andrade TS; Benard G; Martínez R; Bollela VR
Braz J Infect Dis; 2023; 27(4):102793. PubMed ID: 37507102
[TBL] [Abstract][Full Text] [Related]
60. Prevalence of co-existent COVID-19-associated pulmonary aspergillosis (CAPA) and its impact on early mortality in patients with COVID-19-associated pulmonary mucormycosis (CAPM).
Muthu V; Agarwal R; Rudramurthy SM; Thangaraju D; Shevkani MR; Patel AK; Shastri PS; Tayade A; Bhandari S; Gella V; Savio J; Madan S; Hallur V; Maturu VN; Srinivasan A; Sethuraman N; Sibia RPS; Pujari S; Mehta R; Singhal T; Saxena P; Gupta V; Nagvekar V; Prayag P; Patel D; Xess I; Savaj P; Sehgal IS; Panda N; Rajagopal GD; Parwani RS; Patel K; Deshmukh A; Vyas A; Gandra RR; Sistla SK; Padaki PA; Ramar D; Panigrahi MK; Sarkar S; Rachagulla B; Vallandaramam P; Premachandran KP; Pawar S; Gugale P; Hosamani P; Dutt SN; Nair S; Kalpakkam H; Badhwar S; Kompella KK; Singla N; Navlakhe M; Prayag A; Singh G; Dhakecha P; Chakrabarti A
Mycoses; 2024 May; 67(5):e13745. PubMed ID: 38767273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
